Hillsborough, CA, United States of America

Paul J Godowski

Average Co-Inventor Count = 5.3

ph-index = 25

Forward Citations = 2,696(Granted Patents)

Forward Citations (Not Self Cited) = 2,576(Sep 21, 2024)

DiyaCoin DiyaCoin 0.82 

Inventors with similar research interests:


Location History:

  • South San Fran, CA (US) (2000)
  • South San Francisco, CA (US) (2002)
  • Pacifica, CA (US) (1994 - 2003)
  • Hillsborough, CA (US) (2003 - 2012)
  • Burlingame, CA (US) (1996 - 2013)


Years Active: 1994-2013

where 'Filed Patents' based on already Granted Patents

594 patents (USPTO):

Title: Paul J Godowski: Innovator Extraordinaire with 515 Patents

Introduction:

In the world of innovations and patents, Paul J Godowski is a name that shines brightly. Hailing from Hillsborough, CA (US), he has made significant contributions to the fields of biotechnology and the life sciences. With an impressive portfolio of 515 patents, his groundbreaking work has revolutionized the medical industry. This article delves into his latest patents, career highlights, collaborations, and remarkable achievements.

Latest Patents:

Godowski's recent patents showcase his deep understanding of molecular biology and its applications in therapeutics. One such invention is the IL-17 receptor-like polypeptides and therapeutic uses thereof. This patent introduces novel polypeptides with sequence identity to IL-17 and IL-17 receptors, along with nucleic acid molecules encoding these polypeptides. The invention also encompasses vectors, host cells, chimeric polypeptide molecules, and methods for producing these polypeptides. Furthermore, it offers potential treatment options for degenerative cartilaginous disorders and other inflammatory diseases.

Another remarkable patent by Godowski is PRO1120 polypeptides. This invention presents novel polypeptides and the corresponding nucleic acid molecules that encode them. Similar to the previous patent, this invention also includes vectors, host cells, chimeric polypeptide molecules, and methods for producing these polypeptides. The breakthrough discoveries within these patents highlight Godowski's expertise and commitment to advancing medical science.

Career Highlights:

Throughout his illustrious career, Godowski has been associated with renowned companies such as Genentech, Inc. and the New England Deaconess Hospital Corporation. Genentech, Inc., commonly known as Genentech, specializes in biotechnology and has consistently been at the forefront of developing groundbreaking therapies. Working at such an institution speaks volumes about Godowski's expertise and the high regard in which he is held within the industry.

Collaborations:

Innovation often thrives on collaboration, and Godowski has had the privilege of working alongside exceptional individuals during his career. Among his notable coworkers, Austin L Gurney and Audrey Goddard have contributed significantly to his research endeavors. Their collaborations have undoubtedly enriched the inventions and patents they have jointly developed, leaving an indelible mark on the field.

Conclusion:

Paul J Godowski is an outstanding innovator whose contributions to the fields of biotechnology and life sciences have been paramount. With an impressive patent count of 515, his inventions have the potential to transform the way we approach medical treatments and address degenerative cartilaginous disorders and inflammatory diseases. Godowski's career highlights, including his association with esteemed institutions like Genentech, Inc., and his fruitful collaborations with talented coworkers, only further demonstrate his immense expertise and dedication to advancing scientific knowledge. We look forward to witnessing more groundbreaking inventions from this exceptional industry pioneer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…